Cargando…

Cardiovascular and renal outcomes with SGLT-2 inhibitors versus GLP-1 receptor agonists in patients with type 2 diabetes mellitus and chronic kidney disease: a systematic review and network meta-analysis

BACKGROUND: Emerging evidence suggests that sodium-glucose cotransporter-2 (SGLT-2) inhibitors and glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are associated with decreased risk of cardiovascular and renal events in type 2 diabetes mellitus (DM) patients. However, no study to date has comp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yamada, Takayuki, Wakabayashi, Mako, Bhalla, Abhinav, Chopra, Nitin, Miyashita, Hirotaka, Mikami, Takahisa, Ueyama, Hiroki, Fujisaki, Tomohiro, Saigusa, Yusuke, Yamaji, Takahiro, Azushima, Kengo, Urate, Shingo, Suzuki, Toru, Abe, Eriko, Wakui, Hiromichi, Tamura, Kouichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7792332/ https://www.ncbi.nlm.nih.gov/pubmed/33413348 http://dx.doi.org/10.1186/s12933-020-01197-z

Ejemplares similares

Value of leukocytosis and elevated C-reactive protein in predicting severe coronavirus 2019 (COVID-19): A systematic review and meta-analysis
por: Yamada, Takayuki, et al.
Publicado: (2020)

Systematic review and meta-analysis for prevention of cardiovascular complications using GLP-1 receptor agonists and SGLT-2 inhibitors in obese diabetic patients
por: Uneda, Kazushi, et al.
Publicado: (2021)

Systematic Review of the Association Between Worsening Renal Function and Mortality in Patients With Acute Decompensated Heart Failure
por: Yamada, Takayuki, et al.
Publicado: (2020)

Comparative Efficacy of Pharmacological Treatments for Adults With Autosomal Dominant Polycystic Kidney Disease: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
por: Tsukamoto, Shunichiro, et al.
Publicado: (2022)

Effects of tumor necrosis factor-α inhibition on kidney fibrosis and inflammation in a mouse model of aristolochic acid nephropathy
por: Taguchi, Shinya, et al.
Publicado: (2021)

Author Correction: Angiotensin II type-1 receptor-associated protein interacts with transferrin receptor-1 and promotes its internalization
por: Abe, Eriko, et al.
Publicado: (2022)

Angiotensin II type-1 receptor-associated protein interacts with transferrin receptor-1 and promotes its internalization
por: Abe, Eriko, et al.
Publicado: (2022)

Impact of the COVID-19 pandemic on physical and psychological activities in elderly patients with hypertension
por: Azushima, Kengo, et al.
Publicado: (2022)

Aristolochic Acid Induces Renal Fibrosis and Senescence in Mice
por: Urate, Shingo, et al.
Publicado: (2021)

Tissue-specific expression of the SARS-CoV-2 receptor, angiotensin-converting enzyme 2, in mouse models of chronic kidney disease
por: Tsukamoto, Shunichiro, et al.
Publicado: (2021)

Updates for Cardio‐Kidney Protective Effects by Angiotensin Receptor‐Neprilysin Inhibitor: Requirement for Additional Evidence of Kidney Protection
por: Tsukamoto, Shunichiro, et al.
Publicado: (2023)

Effects of a High-Protein Diet on Kidney Injury under Conditions of Non-CKD or CKD in Mice
por: Tanaka, Shohei, et al.
Publicado: (2023)

Combination of sacubitril/valsartan and blockade of the PI3K pathway enhanced kidney protection in a mouse model of cardiorenal syndrome
por: Tsukamoto, Shunichiro, et al.
Publicado: (2023)

Patients with chronic kidney disease have a poorer prognosis of coronavirus disease 2019 (COVID-19): an experience in New York City
por: Yamada, Takayuki, et al.
Publicado: (2020)

Angiotensin II type 1 receptor-associated protein deficiency attenuates sirtuin1 expression in an immortalised human renal proximal tubule cell line
por: Yamaji, Takahiro, et al.
Publicado: (2019)

Effects of Rikkunshito treatment on renal fibrosis/inflammation and body weight reduction in a unilateral ureteral obstruction model in mice
por: Wakui, Hiromichi, et al.
Publicado: (2020)

Tissue xanthine oxidoreductase activity in a mouse model of aristolochic acid nephropathy
por: Ishii, Takeo, et al.
Publicado: (2021)

Effects of rikkunshito on renal fibrosis and inflammation in angiotensin II-infused mice
por: Azushima, Kengo, et al.
Publicado: (2019)

SARS-CoV-2 spike protein antibody titers 6 months after SARS-CoV-2 mRNA vaccination among patients undergoing hemodialysis in Japan
por: Kanai, Daisuke, et al.
Publicado: (2022)

Blood Pressure Elevation of Tubular Specific (P)RR Transgenic Mice and Lethal Tubular Degeneration due to Possible Intracellular Interactions between (P)RR and Alternative Renin Products
por: Saigo, Sae, et al.
Publicado: (2021)

Native T1 time and extracellular volume fraction in differentiation of normal myocardium from non-ischemic dilated and hypertrophic cardiomyopathy myocardium: A systematic review and meta-analysis
por: Minegishi, Shintaro, et al.
Publicado: (2019)

Effects of Single Pill-Based Combination Therapy of Amlodipine and Atorvastatin on Within-Visit Blood Pressure Variability and Parameters of Renal and Vascular Function in Hypertensive Patients with Chronic Kidney Disease
por: Azushima, Kengo, et al.
Publicado: (2014)

Early Enhanced Leucine-Rich α-2-Glycoprotein-1 Expression in Glomerular Endothelial Cells of Type 2 Diabetic Nephropathy Model Mice
por: haku, Sona, et al.
Publicado: (2018)

Eplerenone-Resistant Salt-Sensitive Hypertension in Nedd4-2 C2 KO Mice
por: Kino, Tabito, et al.
Publicado: (2017)

An Isoform of Nedd4-2 Plays a Pivotal Role in Electrophysiological Cardiac Abnormalities
por: Minegishi, Shintaro, et al.
Publicado: (2017)

Comparison of the effects of weekly and biweekly intravenous CERA administration on erythropoiesis: A randomized controlled trial
por: Kawai, Yuki, et al.
Publicado: (2021)

Effects of ATRAP in Renal Proximal Tubules on Angiotensin‐Dependent Hypertension
por: Kinguchi, Sho, et al.
Publicado: (2019)

Bofu-Tsu-Shosan, an Oriental Herbal Medicine, Exerts a Combinatorial Favorable Metabolic Modulation Including Antihypertensive Effect on a Mouse Model of Human Metabolic Disorders with Visceral Obesity
por: Azushima, Kengo, et al.
Publicado: (2013)

Effects of pitavastatin add-on therapy on chronic kidney disease with albuminuria and dyslipidemia
por: Ohsawa, Masato, et al.
Publicado: (2015)

Addition of Aliskiren to Angiotensin Receptor Blocker Improves Ambulatory Blood Pressure Profile and Cardiorenal Function Better than Addition of Benazepril in Chronic Kidney Disease
por: Ohsawa, Masato, et al.
Publicado: (2013)

L/N-Type Calcium Channel Blocker Cilnidipine Added to Renin-Angiotensin Inhibition Improves Ambulatory Blood Pressure Profile and Suppresses Cardiac Hypertrophy in Hypertension with Chronic Kidney Disease
por: Kanaoka, Tomohiko, et al.
Publicado: (2013)

Adipocyte‐Specific Enhancement of Angiotensin II Type 1 Receptor‐Associated Protein Ameliorates Diet‐Induced Visceral Obesity and Insulin Resistance
por: Azushima, Kengo, et al.
Publicado: (2017)

Effects of the Angiotensin Receptor Blocker Olmesartan on Adipocyte Hypertrophy and Function in Mice with Metabolic Disorders
por: Maeda, Akinobu, et al.
Publicado: (2014)

Upstream Stimulatory Factors 1 and 2 Mediate the Transcription of Angiotensin II Binding and Inhibitory Protein
por: Matsuda, Miyuki, et al.
Publicado: (2013)

Effects of Ang II Receptor Blocker Irbesartan on Adipose Tissue Function in Mice with Metabolic Disorders
por: Maeda, Akinobu, et al.
Publicado: (2014)

Angiotensin II Type 1 Receptor-associated Protein Inhibits Angiotensin II-induced Insulin Resistance with Suppression of Oxidative Stress in Skeletal Muscle Tissue
por: Ohki, Kohji, et al.
Publicado: (2018)

Global use of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes. Results from DISCOVER
por: Arnold, Suzanne V., et al.
Publicado: (2022)

Angiotensin Receptor–Binding Protein ATRAP/Agtrap Inhibits Metabolic Dysfunction With Visceral Obesity
por: Maeda, Akinobu, et al.
Publicado: (2013)

Enhancement of intrarenal plasma membrane calcium pump isoform 1 expression in chronic angiotensin II‐infused mice
por: Wakui, Hiromichi, et al.
Publicado: (2017)

SGLT2is vs. GLP1RAs Reduce Cardiovascular and All-Cause Mortality
por: Qiu, Mei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_t1sq9hq23tmu8maogrhlo5r5r5